LIBX-A403 is a potent, selective and reversible ACSL4 inhibitor with a human IC50 of 0.049 µM and a Kd of 0.29 µM. LIBX-A403 binds in the ACSL4 fatty acid pocket in an ATP-dependent manner. LIBX-A403 prevents cell ferroptosis. LIBX-A403 can be used for the researches of cancer and parkinsons disease[1].
Molecular Weight:
363.36
Purity:
98.28
Formula:
C21H17NO5
Target:
ACSL Family,Ferroptosis
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted